Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2025)

Phibro Animal Health has reported Share-based Compensation over the past 6 years, most recently at $180000.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $180000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $877000.0 (up 30.31% YoY), and the annual figure for FY2025 was $717000.0, up 50.95%.
  • Share-based Compensation for Q4 2025 was $180000.0 at Phibro Animal Health, down from $339000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for PAHC hit a ceiling of $339000.0 in Q3 2025 and a floor of $80000.0 in Q4 2023.
  • Median Share-based Compensation over the past 3 years was $179000.0 (2024), compared with a mean of $171100.0.
  • Biggest five-year swings in Share-based Compensation: surged 125.0% in 2024 and later changed 0.0% in 2025.
  • Phibro Animal Health's Share-based Compensation stood at $80000.0 in 2023, then surged by 125.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025.
  • The last three reported values for Share-based Compensation were $180000.0 (Q4 2025), $339000.0 (Q3 2025), and $179000.0 (Q2 2025) per Business Quant data.